Status:

COMPLETED

Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes

Lead Sponsor:

University Hospital, Grenoble

Conditions:

Myelodysplastic Syndromes

Chronic Myelomonocytic Leukemia

Eligibility:

All Genders

50+ years

Brief Summary

Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal bone marrow neoplasms that predominate in the elderly, with a median age at diagnosis of 70 years. MDS are characterized by p...

Detailed Description

The primary objective of MPO-MDS-pilot study is to estimate the accuracy of flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for the diagnosis of myelodysplastic s...

Eligibility Criteria

Inclusion

  • Age ≥50 years;
  • Clinical suspicion of myelodysplastic syndromes (MDS) and / or chronic myelomonocytic leukemia (CMML);
  • Peripheral blood cytopenia defined by hemoglobin concentration \<10 g/dL, platelet count \<100 x109/L, and/or absolute neutrophil count \<1.8 x109/L.

Exclusion

  • History of or active documented MDS or CMML;
  • Admission to the intensive care unit;
  • Suspicion of hematological disease other than MDS requiring bone marrow aspirate and/or biopsy (i.e., acute leukemia,…);
  • Absolute neutrophil count \<0.5 x109/L;
  • Not affiliated with a social security system;
  • Homelessness;
  • Incarcerated;
  • Inability to understand research information and/or to provide non-opposition, because of language restriction, dementia, or altered mental status;
  • Refusal to participate;
  • Previous enrollment in the study.

Key Trial Info

Start Date :

February 22 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 6 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03363399

Start Date

February 22 2018

End Date

September 6 2018

Last Update

September 25 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centre Hospitalier Universitaire Estaing

Clermont-Ferrand, France, 63003

2

Centre Hospitalier Universitaire Grenoble Alpes

Grenoble, France, 38043

Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes | DecenTrialz